BioPorto A/S
BIOPOR
Rankning i aktier
#22848
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Aktiekurs
$0.16115447
Marknadsvärde
$79.79M
Förändring (1 dag)
-1.46%
Förändring (1 år)
-44.04%
Land
DK
Handel BioPorto A/S (BIOPOR)
Kategori
Healthcare
Historik för aktiesplit för BioPorto A/S (BIOPOR)
Aktien BioPorto A/S (symbol: BIOPOR) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En BIOPOR-aktie köpt före Oct 21, 2026 motsvarar nu 0 BIOPOR-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En BIOPOR-aktie köpt före Oct 21, 2026 motsvarar nu 0 BIOPOR-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
